Evaluating the effects of single and combined chelators therapies on spatial learning and memory impairments in chronic manganese poisoning

References

• Aghaei I, Shabani M, Doustar N, et al (2014). Peroxisome proliferator-activated receptor-γ activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis. Pharmacol Biochem Behav 120:133–9
   PubMed Web of Science ®Google Scholar
• Aschner M. (1996). The functional significance of brain metallothioneins. FASEB J 10:1129–36
   PubMed Web of Science ®Google Scholar
• Aschner M, Guilarte TR, Schneider JS, Zheng W. (2007). Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharm 221:131–47
   PubMed Web of Science ®Google Scholar
• Bouchard M, Mergler D, Baldwin ME, Panisset M. (2008). Manganese cumulative exposure and symptoms: a follow-up study of alloy workers. NeuroToxicology 29:577–83
   PubMed Web of Science ®Google Scholar
• Cappellini MD. (2008). Long-term efficacy and safety of deferasirox. Blood Rev 22:S35–41
   PubMed Web of Science ®Google Scholar
• Cassinerio E, Orofino N, Roghi A, et al (2014). Combination of deferasirox and deferoxamine in clinical practice: an alternative scheme of chelation in thalassemia major patients. Blood Cell Mol Dis 53:164–7
   PubMed Web of Science ®Google Scholar
• Cermak J, Jonasova A, Vondrakova J, et al (2013). A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes. Leukemia Res 37:1612–15
   PubMed Web of Science ®Google Scholar
• Chan AW, Minski MJ, Lim L, Lai JC. (1992). Changes in brain regional manganese and magnesium levels during postnatal development: modulations by chronic manganese administration. Metab Brain Dis 7:21–33
   PubMed Web of Science ®Google Scholar
• Crossgrove JS, Allen DD, Bukaveckas BL, et al (2003). Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of managanese citrate as well as manganese and manganese transferrin. NeuroToxicol 24:3–13
   PubMed Web of Science ®Google Scholar
• Crossgrove JS, Yokel RA. (2005). Manganese distribution across the blood–brain barrier IV. Evidence for brain influx through store-operated calcium channels. NeuroToxicol 26:297–307
   PubMed Web of Science ®Google Scholar
• D’Hooge R, De Deyn PP. (2001). Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60–90
   PubMed Web of Science ®Google Scholar
• Erikson K, Aschner M. (2002). Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. NeuroToxicol 23:595–602
   PubMed Web of Science ®Google Scholar
• Erikson KM, Syversen T, Aschner JL, Aschner M. (2005). Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ Toxicol Phar 19:415–21
   PubMed Web of Science ®Google Scholar
• Fatemi SJ, Amiri A, Bazargan MH, et al (2007). Clinical evaluation of desferrioxamine (DFO) for removal of thallium ions in rat. Int J Artif Organs 30:902–5
   PubMed Web of Science ®Google Scholar
• Fatemi SJ, Khajoee NF, Zandevakili T, Dahoee Balooch F. (2014). Chelation of cobalt by combining deferasirox, deferiprone and desferrioxamine in rats. Toxin Rev 33:146–50
   Web of Science ®Google Scholar
• Fatemi SJ, Shokooh-Saljooghi A, Dahooee Balooch F, et al (2011). Chelation of cadmium by combining deferasirox and deferiprone in rats. Toxicol Ind Health 27:371–7
   PubMed Web of Science ®Google Scholar
• Finkelstein Y, Zhange N, Fitsanakis VA, et al (2008). Differential deposition of manganese in the rat brain following subchronic exposure to manganese: a T1-weighted magnetic resonance imaging study. Israel Med Assoc J 10:793–8
   PubMed Web of Science ®Google Scholar
• Gómez M, Esparza JL, Domingo JL, et al (1998). Comparative aluminium mobilizing action of desferrioxamine and four 3-hydroxypyrid-4-ones in aluminium-loaded rats. Toxicology 130:175–81
   PubMed Web of Science ®Google Scholar
• Gwiazda RH, Lee D, Sheridan J, Smith DR. (2002). Low cumulative manganese exposure affects striatal GABA but not dopamine. NeuroToxicol 23:69–76
   PubMed Web of Science ®Google Scholar
• Hajali V, Sheibani V, Esmaeili-Mahani S, Shabani M. (2012). Female rats are more susceptible to the deleterious effects of paradoxical sleep deprivation on cognitive performance. Behav Brain Res 228:311–18
   PubMed Web of Science ®Google Scholar
• Iranmanesh M, Fatemi SJ, Ebrahimpour R, Dahooee Balooch F. (2013). Chelation of chromium(VI) by combining deferasirox and deferiprone in rats. Biometals 26:465–71
   PubMed Web of Science ®Google Scholar
• Kern CH. (2009). Neurotoxicity of neonatal manganese exposure. Santa Cruz, CA: University of California
   Google Scholar
• Khajoee NF, Fatemi SJ, Sheibani V. (2013). An investigation of cobalt toxicity on blood parameters and evaluationof deferasirox and desferrioxamine chelators in removing cobalt from biological system. Toxin Rev 33:53–9
   Web of Science ®Google Scholar
• Legssyer R, Josse C, Piette J, et al (2003). Changes in function of iron-loaded alveolar macrophages after in vivo administration of desferrioxamine and/or chloroquine. J Inorg Biochem 94:36–42
   PubMed Web of Science ®Google Scholar
• Naghdi N, Majlessi N, Bozorgmehr T. (2003). The effects of anisomycin (a protein synthesis inhibitor) on spatial learning and memory in CA1 region of rats hippocampus. Behav Brain Res 139:69–73
   PubMed Web of Science ®Google Scholar
• Narita K, Kawasaki F, Kita H. (1990). Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs. Brain Res 510:289–95
   PubMed Web of Science ®Google Scholar
• Neufeld EJ. (2006). Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood 107:3436–41
   PubMed Web of Science ®Google Scholar
• Normandin L, Beaupre LA, Salehi F, et al (2004). Manganese distribution in the brain and neurobehavioral changes following inhalation exposure of rats to three chemical form of manganese. NeuroToxicol 25:433–41
   PubMed Web of Science ®Google Scholar
• Öner G, ŞentÜrk ÜK. (1995). Reversibility of manganese-induced learning defect in rats. Food Chem Toxicol 33:559–63
   PubMed Web of Science ®Google Scholar
• Pecze L, Papp A, Nagymajtenyi L. (2004). Changes in the spontaneous and stimulus-evoked activity in the somatosensory cortex of rats on acute manganese administration. Toxicol Lett 148:125–31
   PubMed Web of Science ®Google Scholar
• Phattanarudee S. (2009). Long-term neurobehavioral effects of in utero and lactational exposure to manganese and lead in rats. Massachusetts College of Pharmacy and Health Sciences, 180 pages; 3361096
   Google Scholar
• Porter JB. (2009). Optimizing iron chelation strategies in β-thalassaemia major. Blood Rev 23:S3–7
   PubMed Web of Science ®Google Scholar
• Reaney SH, Bench G, Smith DR. (2006). Brain accumulation and toxicity of Mn(II) and Mn(III) exposures. Toxicol Sci 93:114–24
   PubMed Web of Science ®Google Scholar
• Scott LE, Orvig C. (2009). Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in diseases. Chem Rev 109:4885–910
   PubMed Web of Science ®Google Scholar
• Shukakidze A, Lazriev I, Mitagvariya N. (2003). Behavioral impairments in acute and chronic manganese poisoning in white rats. Neurosci Behav Physiol 33:263–7
   PubMedGoogle Scholar
• Takeda A, Sawashita J, Okada S. (1998). Manganese concentration in rat brain: manganese transport from the peripheral tissues. Neurosci Lett 242:45–8
   PubMed Web of Science ®Google Scholar
• Tran TT, Chowanadisai W, Lonnerdal B, et al (2002). Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive functions. NeuroToxicol 23:645–51
   PubMed Web of Science ®Google Scholar
• Vezér T, Papp A, Hoyk Z, et al (2005). Behavioral and neurotoxicological effects of subchronic manganese exposure in rats. Environ Toxicol Pharmacol 19:797–810
   PubMed Web of Science ®Google Scholar
• Voskaridou E, Christoulas D, Terpos E. (2011). Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies. Brit J Haematol 154:654–6
   PubMed Web of Science ®Google Scholar
• Yamada M, Ohno S, Okayasu I, et al (1986). Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 70:273–8
   PubMed Web of Science ®Google Scholar
• Zheng W, Jiang YM, Zhang Y, et al (2009). Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in Sprague-Dawley rats. NeuroToxicol 30:240–8
   PubMed Web of Science ®Google Scholar